← back to search

Jürgen Meixensberger

University Hospital Leipzig ·
Area of research
Neurology · Cellular and Molecular Neuroscience
Research interest
Research interests include Traumatic Brain Injury and Neurovascular Disturbances, Intracranial Aneurysms: Treatment and Complications, Cerebrospinal fluid and hydrocephalus, and Glioma Diagnosis and Treatment.
h-index
32
citations
5,164
works
177
NIH funding
primary concept
email

Recent publications

Predictors of psychiatric comorbidity in cancer patients at the time of their discharge from the hospital
Social Psychiatry and Psychiatric Epidemiology 2021cited by 11position: middledoi
Superiority of temozolomide over radiotherapy for elderly patients with RTK II methylation class, MGMT promoter methylated malignant astrocytoma
Neuro-Oncology 2020cited by 73position: middledoi
Single-Dose Intraventricular Nimodipine Microparticles Versus Oral Nimodipine for Aneurysmal Subarachnoid Hemorrhage
Stroke 2020cited by 72position: middledoi
Glioma patients in outpatient care—optimization of psychosocial care in neuro-oncological patients (GLIOPT): Protocol for a cluster randomized controlled trial
Trials 2020cited by 12position: middledoi
The association of socioeconomic status with quality of life in cancer patients over a 6-month period using individual growth models
Supportive Care in Cancer 2019cited by 28position: middledoi
Psychiatric co-morbidity, distress, and use of psycho-social services in adult glioma patients—a prospective study
Acta Neurochirurgica 2018cited by 40position: lastdoi
Factors associated with non-participation and dropout among cancer patients in a cluster-randomised controlled trial
European Journal of Cancer Care 2017cited by 40position: middledoi
<i>MGMT</i> Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial
Clinical Cancer Research 2015cited by 316position: middledoi
Hemicraniectomy in Older Patients with Extensive Middle-Cerebral-Artery Stroke
New England Journal of Medicine 2014cited by 612position: middledoi
Reirradiation in progressive high-grade gliomas: outcome, role of concurrent chemotherapy, prognostic factors and validation of a new prognostic score with an independent patient cohort
Radiation Oncology 2013cited by 54position: middledoi
Neurosurgery
2013cited by 0position: lastdoi
Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial
The Lancet Oncology 2012cited by 1,120position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 6 papers (2012–2021)Susanne Singer · University Medical Center Freiburg5 papers (2017–2021) · 4 papers (2017–2021) · 4 papers (2017–2021) · 3 papers (2017–2021)Hubert Wirtz · Berlin Institute of Health at Charité - Universitätsmedizin Berlin3 papers (2017–2021)Arne Dietrich · University Hospital Heidelberg3 papers (2017–2021)Andreas Dietz · Accadis Hochschule Bad Homburg3 papers (2017–2021)Regine Mayer‐Steinacker · University Hospital Ulm2 papers (2012–2020)Mirjam Renovanz · University Children's Hospital Tübingen2 papers (2018–2020)Guido Reifenberger · University of Toronto2 papers (2012–2020) · 2 papers (2012–2020)Michael Weller · Center for Neurosciences2 papers (2012–2020)Stephanie E. Combs · Brooke Army Medical Center2 papers (2012–2013)Ralf Ketter · Saarland University2 papers (2012–2020)Rolf‐Dieter Kortmann · University Medical Center2 papers (2013–2018)Jörg Felsberg · Düsseldorf University Hospital2 papers (2012–2020)Michael Platten · German Cancer Research Center2 papers (2012–2020)Joachim P. Steinbach · Goethe University Frankfurt2 papers (2012–2020)Michael Sabel · Düsseldorf University Hospital2 papers (2012–2020)